VISEN PHARMA-B (HKEX: 02561) has issued an announcement regarding the grant of share-based incentives.
On July 20, 2026, the company, under its established incentive plan, granted a total of 514,000 share awards to 19 eligible recipients.
The recipients are comprised of the company's senior management personnel and employees of the group. The awards are conditional upon acceptance by the grantees to become effective.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments